우리는 아픈 사람이 다시 건강해지도록 돕기 위해 종종 약을 투여합니다. 하지만 우리는 질병을 완전히 예방할 수 있을 수도 있습니다. 입력 : 백신! 백신에 가장 가까운 것은 신체 주위에 보호막을 제공하여 면역체계가 침입자가 있는지 파악하고 침입자가 퍼지기 전에 싸울 수 있도록 하는 파워업 수정과 같습니다. 백신은 우리가 쉽게 병에 걸리는 것을 예방하고 많은 질병을 예방하는 데 도움이 됩니다.
많은 질병은 바이러스나 박테리아와 같은 세균에 의해 발생합니다.e. 홍역, 독감 심지어 코로나19도 우리를 매우 아프게 만들 수 있는 바이러스성 질병이므로, 이로부터 자신을 보호할 방법을 찾는 것이 중요합니다. 우리 몸은 이러한 유해한 세균을 보고 심지어 VLP 백신에 속아서 그와 똑같이 보일 수도 있습니다. 우리 몸은 이러한 VLP를 만나면 실제 세균이 복수할 때 다시 공격하는 방법을 빠르게 배울 수 있습니다.
VLP vaccines - VPP begins with construction of a small virus-like particle in the lab. But fear not, because these particles are NOT contagious to humans! Scientists insert tiny bits of the germs that these vaccines will provide protection which is also known as VLPs.
VLP 백신은 백신 과학 분야의 발전입니다. 대규모로 빠르고 쉽게 생산할 수 있으므로 긴급 상황이나 질병이 발생할 때 사람들을 보호할 수 있는 더 나은 장비를 갖추게 됩니다. 그들은 또한 우리를 질병으로부터 안전하게 지켜주는 데 능숙합니다! 세균이 거의 하룻밤 사이에 진화하는 것처럼 보이는 오늘날에는 더욱 그렇습니다.
VLP 기술은 신기술(예: 코로나19 백신에 사용되는 mRNA 등)과도 제휴할 수 있습니다. mRNA는 신체에 지시를 내리는 유전 물질의 일종입니다. mRNA와 함께 VLP를 사용하면 연구자들은 우리 몸에 세균과 더 효과적으로 싸우는 방법을 가르치는 백신을 개발할 수 있습니다. 결합하면 실패할 가능성이 더 적은 더 강력한 백신을 얻을 수 있습니다.
Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and VLP-based Vaccine Manufacturing. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.
Yaohai Bio-Pharma is a leading in VLP-based Vaccine Manufacturing CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.
Yaohai Bio-Pharma, a top 10 VLP-based Vaccine Manufacturing of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.
Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as VLP-based Vaccine Manufacturing of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.
Yaohai Bio-Pharma는 14년 동안 미생물 CRDMO 솔루션에 주력해 왔습니다. 우리는 전 세계 고객에게 원스톱 생물학적 제제 서비스를 제공합니다.
No. 801, Jiankang Avenue, Taizhou, Jiangsu, China
저작권 © 야오하이 바이오제약 주식회사 판권 소유 | 개인정보 처리방침
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
아니
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
